Change in the number of votes relating to Biotie Therapies Corp.'s shares

 | Source: Biotie Therapies Biotie Therapies 

Biotie Therapies Corp.          Stock Exchange Release    3 August 2011 at 9
a.m.

Change in the number of votes relating to Biotie Therapies Corp.'s shares

The Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"),
Biotie Therapies Holding AG (previously Synosia Therapeutics Holding AG) has
conveyed  Biotie shares  Biotie shares against consideration pursuant to the
option programs as follows:

July 2011 Total      Options outstanding % of the total
          (5-7/2011)                      amount of
                                         shares

374.161   3.406.092  11.304.399          2,9




The conveyance of Biotie shares relates to the option plan of Synosia
Therapeutics Holding AG (currently Biotie Therapies Holding AG, "Synosia")
acquired by Biotie in February 2011. According to such Synosia share option
plan, options have been granted to employees, former directors and consultants.
In connection with the completion of the acquisition of Synosia, the option plan
was amended so that instead of shares in Synosia an aggregate maximum of
14,912,155 shares in Biotie may be subscribed based on the plan. Biotie issued
these 14,912,155 shares to its current subsidiary Synosia in connection with the
acquisition to be further conveyed to the option holders when they potentially
exercise their option rights in accordance with the terms and conditions of the
option program.

The conveyed shares previously held by the Company's subsidiary have not carried
any voting rights.  The parent company Biotie does not own any treasury shares.
The conveyance does not affect the number of registered shares.

After the conveyances the changes are as follows:

The increase of A total amount of The number of the     The total number
 votes of the    voting rights:    Company's share held  of registered
 Company                          by the Group          shares
July 2011                         July 2011:

374.161         376.088.394       11.506.063            387.594.457






Turku, 3 August 2011

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi@biotie.com

DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com


[HUG#1535797]